Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 28-38
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.28
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.28
Figure 3 Overall survival in advanced gastric cancer patients in the early and elective wait time groups.
There was a difference in median survival time between the early and elective wait time groups (230 d vs 340 d, respectively, log-rank test P = 0.0537, Wilcoxon test P = 0.0188). WT: Wait time.
- Citation: Nishida T, Sugimoto A, Tomita R, Higaki Y, Osugi N, Takahashi K, Mukai K, Matsubara T, Nakamatsu D, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M. Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors. World J Gastrointest Oncol 2019; 11(1): 28-38
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/28.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.28